Overview

Pharmacokinetic and Pharmacodynamic Effects of Insulex R in Comparison to Humulin R in Healthy Subjects

Status:
COMPLETED
Trial end date:
2025-05-07
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate whether Insulex R demonstrates similar pharmacokinetic (PK) and pharmacodynamic (PD) profiles compared to Humulin R after a single subcutaneous dose of 0.3 units/kg in healthy adult volunteers.
Phase:
PHASE1
Details
Lead Sponsor:
Laboratorios Pisa S.A. de C.V.
Collaborator:
ProSciento, Inc.
Treatments:
Biosimilar Pharmaceuticals